MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41467-024-49842-5

Медицинская библиотека · Nature communications · 2024

A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.

Zhang Min, Bzura Aleksandra, Baitei Essa Y, Zhou Zisen, Spicer Jake B, Poile Charlotte, Rogel Jan, Branson Amy, King Amy, Barber Shaun, Kamata Tamihiro, Dzialo Joanna, Harber James, Greystoke Alastair, Nusrat Nada, Faulkner Daniel, Sun Qianqian, Nolan Luke, Hahne Jens C, Scotland Molly, Walter Harriet, Darlison Liz, Morgan Bruno, Bajaj Amrita, Brookes Cassandra, Hollox Edward J, Lubawska Dominika, Jama Maymun, Griffiths Gareth, Nakas Apostolos, Kutywayo Kudzayi, Luo Jin-Li, Klampatsa Astero, Cooper Andrea, Halder Koirobi, Wells-Jordan Peter, Zhou Huiyu, Dudbridge Frank, Thomas Anne, Richards Catherine Jane, Pritchard Catrin, Yang Hongji, Barer Michael, Fennell Dean A

СтатьяКлиническое исследование II фазыМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Malignant mesothelioma is a rare tumour caused by asbestos exposure that originates mainly from the pleural lining or the peritoneum. Treatment options are limited, and the prognosis is dismal. Although immune checkpoint blockade (ICB) can improve survival outcomes, the determinants of responsiveness remain elusive. Here, we report the outcomes of a multi-centre phase II clinical trial (MiST4, NCT03654833) evaluating atezolizumab and bevacizumab (AtzBev) in patients with relapsed mesothelioma. We also use tumour tissue and gut microbiome sequencing, as well as tumour spatial immunophenotyping to identify factors associated with treatment response. MIST4 met its primary endpoint with 50% 12-week disease control, and the treatment was tolerable. Aneuploidy, notably uniparental disomy (UPD), homologous recombination deficiency (HRD), epithelial-mesenchymal transition and inflammation with CD68+ monocytes were identified as tumour-intrinsic resistance factors. The log-ratio of gut-resident microbial genera positively correlated with radiological response to AtzBev and CD8+ T cell infiltration, but was inversely correlated with UPD, HRD and tumour infiltration by CD68+ monocytes. In summary, a model is proposed in which both intrinsic and extrinsic determinants in mesothelioma cooperate to modify the tumour microenvironment and confer clinical sensitivity to AtzBev. Gut microbiota represent a potentially modifiable factor with potential to improve immunotherapy outcomes for individuals with this cancer of unmet need.

Для цитирования: Zhang Min, Bzura Aleksandra, Baitei Essa Y, Zhou Zisen, Spicer Jake B, Poile Charlotte, Rogel Jan, Branson Amy, King Amy, Barber Shaun, Kamata Tamihiro, Dzialo Joanna, Harber James, Greystoke Alastair, Nusrat Nada, Faulkner Daniel, Sun Qianqian, Nolan Luke, Hahne Jens C, Scotland Molly, Walter Harriet, Darlison Liz, Morgan Bruno, Bajaj Amrita, Brookes Cassandra, Hollox Edward J, Lubawska Dominika, Jama Maymun, Griffiths Gareth, Nakas Apostolos, Kutywayo Kudzayi, Luo Jin-Li, Klampatsa Astero, Cooper Andrea, Halder Koirobi, Wells-Jordan Peter, Zhou Huiyu, Dudbridge Frank, Thomas Anne, Richards Catherine Jane, Pritchard Catrin, Yang Hongji, Barer Michael, Fennell Dean A. A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.. Nature communications. 2024. DOI: 10.1038/s41467-024-49842-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.